BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32987287)

  • 1. Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells.
    Cheng G; Hardy M; Zielonka J; Weh K; Zielonka M; Boyle KA; Abu Eid M; McAllister D; Bennett B; Kresty LA; Dwinell MB; Kalyanaraman B
    Cancer Treat Res Commun; 2020; 25():100210. PubMed ID: 32987287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research.
    Kalyanaraman B
    FASEB J; 2022 Apr; 36(4):e22226. PubMed ID: 35233843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation.
    Boyle KA; Van Wickle J; Hill RB; Marchese A; Kalyanaraman B; Dwinell MB
    J Biol Chem; 2018 Sep; 293(38):14891-14904. PubMed ID: 30087121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
    Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
    Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
    Vashisht Gopal YN; Gammon S; Prasad R; Knighton B; Pisaneschi F; Roszik J; Feng N; Johnson S; Pramanik S; Sudderth J; Sui D; Hudgens C; Fischer GM; Deng W; Reuben A; Peng W; Wang J; McQuade JL; Tetzlaff MT; Di Francesco ME; Marszalek J; Piwnica-Worms D; DeBerardinis RJ; Davies MA
    Clin Cancer Res; 2019 Nov; 25(21):6429-6442. PubMed ID: 31439581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of B-Raf
    Hong SK; Starenki D; Wu PK; Park JI
    Cancer Biol Ther; 2017 Feb; 18(2):106-114. PubMed ID: 27786591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition.
    Trotta AP; Gelles JD; Serasinghe MN; Loi P; Arbiser JL; Chipuk JE
    J Biol Chem; 2017 Jul; 292(28):11727-11739. PubMed ID: 28546431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.
    Kaushik G; Ramalingam S; Subramaniam D; Rangarajan P; Protti P; Rammamoorthy P; Anant S; Mammen JM
    Am J Surg; 2012 Dec; 204(6):868-73. PubMed ID: 23231930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma.
    Emran AA; Chinna Chowdary BR; Ahmed F; Hammerlindl H; Huefner A; Haass NK; Schuehly W; Schaider H
    Cancer Med; 2019 Mar; 8(3):1186-1196. PubMed ID: 30793515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway.
    Park JB; Lee MS; Cha EY; Lee JS; Sul JY; Song IS; Kim JY
    Biol Pharm Bull; 2012; 35(9):1614-20. PubMed ID: 22975518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
    Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY
    Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
    Xian YF; Qu C; Liu Y; Ip SP; Yuan QJ; Yang W; Lin ZX
    Oxid Med Cell Longev; 2020; 2020():5920476. PubMed ID: 32714487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
    Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma.
    Gopal YN; Rizos H; Chen G; Deng W; Frederick DT; Cooper ZA; Scolyer RA; Pupo G; Komurov K; Sehgal V; Zhang J; Patel L; Pereira CG; Broom BM; Mills GB; Ram P; Smith PD; Wargo JA; Long GV; Davies MA
    Cancer Res; 2014 Dec; 74(23):7037-47. PubMed ID: 25297634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
    Wang TH; Fang JY; Wu SJ; Liu YW; Chan CW; Chuang SY; Chen CY
    Cell Physiol Biochem; 2018; 50(3):883-892. PubMed ID: 30355952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells.
    Kim GD; Oh J; Park HJ; Bae K; Lee SK
    Int J Oncol; 2013 Aug; 43(2):600-10. PubMed ID: 23708970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.
    Singh K; Roy M; Prajapati P; Lipatova A; Sripada L; Gohel D; Singh A; Mane M; Godbole MM; Chumakov PM; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1460-1476. PubMed ID: 30802640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
    Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z
    J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.